Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic diltiazem for prevention of cisplatin-related hearing loss
IRCT20081202001483N4Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Hypoacusis comparing Ear receiving diltiazem solution with Ear receiving placebo (2 arms). Primary endpoint: Hearing Loss. Started Sep 2018; status: completed.
02
Drugs
diltiazem
03
Conditions
Hypoacusis
Beyond the preview
Go deeper on IRCT20081202001483N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081202001483N4.